- Home
- Results news
- AksharChem India
- Q2 FY27 results
AksharChem India Q2 FY27 results: net profit ₹13.32 crore vs ₹1.37 crore loss, revenue up 79.7%
AksharChem India Limited reported standalone revenue of ₹160.48 crore in Q2 FY27, up 79.7% from Q2 FY26, with EBITDA of ₹20.97 crore and a net profit of ₹13.32 crore against a net loss of ₹1.37 crore a year ago. Against Q1 FY27, revenue rose 13.9%, while EBITDA fell 7.3%, EBITDA margin declined 3.0 percentage points and net profit fell 12.4%.
Key points
- Standalone Q2 FY27 revenue was ₹160.48 crore, up ₹71.18 crore or 79.7% from ₹89.30 crore in Q2 FY26.
- EBITDA was ₹20.97 crore, up ₹18.62 crore from ₹2.35 crore, while EBITDA margin rose 10.5 percentage points to 13.1%.
- The company reported a net profit of ₹13.32 crore in Q2 FY27, against a net loss of ₹1.37 crore in Q2 FY26; basic EPS was ₹16.58.
- Against Q1 FY27, revenue rose ₹19.61 crore to ₹160.48 crore, but net profit fell ₹1.89 crore to ₹13.32 crore and basic EPS fell to ₹16.58.
- In H1 FY27, revenue rose 61.8% to ₹301.35 crore, while profit before tax turned to ₹30.03 crore and net profit turned to ₹28.53 crore.
How did AksharChem India perform in Q2 FY27?
AksharChem India reported standalone revenue of ₹160.48 crore for Q2 FY27, up ₹71.18 crore or 79.7% from ₹89.30 crore in Q2 FY26. EBITDA increased ₹18.62 crore to ₹20.97 crore, while EBITDA margin expanded 10.5 percentage points to 13.1%. Profit before tax was ₹14.09 crore against a loss of ₹1.40 crore, and the company reported a net profit of ₹13.32 crore against a net loss of ₹1.37 crore. Basic EPS was ₹16.58.
Sequentially, revenue rose ₹19.61 crore or 13.9% from ₹140.87 crore in Q1 FY27, while total income rose ₹19.62 crore to ₹160.52 crore. EBITDA fell ₹1.65 crore or 7.3% to ₹20.97 crore, and EBITDA margin declined 3.0 percentage points from 16.1%. Profit before tax fell ₹1.86 crore to ₹14.09 crore, while net profit declined ₹1.89 crore to ₹13.32 crore and basic EPS fell ₹2.36 to ₹16.58.
The reported results are standalone for the July–September 2026 quarter. No consolidated result for the quarter was provided in the filings or the supplied financial data.
| ₹ crore | Q2 FY27 | Q1 FY27 | Q2 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 160.48 | 140.87 | 89.30 | +79.7% | +13.9% |
| Other income | 0.03 | 0.03 | 0.03 | +0.0% | +0.0% |
| Total expenses | 146.43 | 124.96 | 92.44 | +58.4% | +17.2% |
| EBITDA | 20.97 | 22.62 | 2.35 | +792.3% | −7.3% |
| EBITDA margin | 13.1% | 16.1% | 2.6% | +10.5 pp | −3.0 pp |
| Profit before tax | 14.09 | 15.95 | −1.40 | turned to profit | −11.7% |
| Tax | 0.76 | 0.74 | −0.04 | +2.7% | |
| Net profit | 13.32 | 15.21 | −1.37 | turned to profit | −12.4% |
| EPS (₹) | 16.58 | 18.94 | −1.70 | turned to profit | −12.5% |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in AksharChem India's costs and profit?
Total expenses rose ₹53.99 crore or 58.4% to ₹146.43 crore from ₹92.44 crore in Q2 FY26. Cost of materials accounted for the largest increase, rising ₹39.67 crore or 88.6% to ₹84.45 crore. Other expenses were higher by ₹6.76 crore or 22.1% at ₹37.38 crore, finance costs rose ₹1.09 crore or 79.0% to ₹2.47 crore, and employee cost increased ₹0.56 crore or 14.2% to ₹4.49 crore.
Depreciation rose ₹0.34 crore or 8.3% to ₹4.45 crore, while other income was unchanged at ₹0.03 crore. Q2 FY26 included an exceptional gain of ₹1.70 crore, whereas Q2 FY27 had no exceptional item. Tax moved from a credit of ₹0.04 crore in Q2 FY26 to a charge of ₹0.76 crore, a difference of ₹0.80 crore.
Against Q1 FY27, total expenses increased ₹21.47 crore or 17.2% to ₹146.43 crore. Other expenses fell ₹3.95 crore or 9.6% to ₹37.38 crore and cost of materials fell ₹0.12 crore or 0.1% to ₹84.45 crore, while employee cost rose ₹0.34 crore or 8.2%, finance costs rose ₹0.14 crore or 6.0% and depreciation rose ₹0.08 crore or 1.8%. Other income was unchanged at ₹0.03 crore, and there was no exceptional item.
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 84.45 | 44.78 | +39.67 | +88.6% |
| Employee cost | 4.49 | 3.93 | +0.56 | +14.2% |
| Finance costs | 2.47 | 1.38 | +1.09 | +79.0% |
| Depreciation | 4.45 | 4.11 | +0.34 | +8.3% |
| Other expenses | 37.38 | 30.62 | +6.76 | +22.1% |
| Total expenses | 146.43 | 92.44 | +53.99 | +58.4% |
| Other income | 0.03 | 0.03 | 0 | +0.0% |
| Tax | 0.76 | −0.04 | +0.80 | |
| Exceptional items | none | +1.70 (gain) |
Source: Company's results filing (XBRL).
How did the first half of FY27 go?
In the first half of FY27, standalone revenue was ₹301.35 crore, up ₹115.09 crore or 61.8% from ₹186.26 crore in H1 FY26. Total income rose 61.8% to ₹301.42 crore from ₹186.34 crore. Profit before tax turned to ₹30.03 crore from a loss of ₹0.37 crore, an improvement of ₹30.4 crore.
Net profit in H1 FY27 was ₹28.53 crore, compared with a net loss of ₹0.66 crore in H1 FY26, an improvement of ₹29.19 crore. Basic EPS was ₹35.52, against negative EPS of ₹0.82 in the previous first half, a difference of ₹36.34.
| ₹ crore | H1 FY27 | H1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 301.35 | 186.26 | +61.8% |
| Profit before tax | 30.03 | −0.37 | turned to profit |
| Net profit | 28.53 | −0.66 | turned to profit |
| EPS (₹) | 35.52 | −0.82 |
Source: Company's results filing (XBRL).
What do the balance sheet and cash flow show?
At 30 September 2026, total assets were ₹499.51 crore against ₹451.61 crore at 31 March 2026, while total equity was ₹290.07 crore against ₹261.53 crore. Borrowings fell to ₹103.78 crore from ₹108.46 crore, and cash was ₹0.17 crore compared with ₹0.15 crore. Inventories increased to ₹85.72 crore from ₹73.01 crore, trade receivables to ₹96.98 crore from ₹62.41 crore, and trade payables to ₹77.72 crore from ₹53.95 crore.
Operating cash flow in H1 FY27 was ₹16.0 crore, compared with ₹10.77 crore in H1 FY26. Investing cash flow was negative ₹6.32 crore against negative ₹15.2 crore, while financing cash flow was negative ₹9.66 crore against positive ₹4.4 crore. Capital expenditure was ₹6.4 crore, compared with ₹15.28 crore a year earlier.
| ₹ crore | As of 30 September 2026 | As of 31 March 2026 |
|---|---|---|
| Total assets | 499.51 | 451.61 |
| Total equity | 290.07 | 261.53 |
| Borrowings | 103.78 | 108.46 |
| Cash and equivalents | 0.17 | 0.15 |
| Inventories | 85.72 | 73.01 |
| Trade receivables | 96.98 | 62.41 |
Source: Company's results filing (XBRL).
| ₹ crore | H1 FY27 | H1 FY26 |
|---|---|---|
| Cash from operations | 16 | 10.77 |
| Cash from investing | −6.32 | −15.20 |
| Cash from financing | −9.66 | 4.40 |
| Capital expenditure | 6.40 | 15.28 |
Source: Company's results filing (XBRL).
How has AksharChem India done over the last 8 quarters?
Revenue rose in each of the last three quarters on a year-on-year basis. Across the quarterly trend, revenue reached ₹160.48 crore in Q2 FY27, up from ₹80.38 crore in Q3 FY26, when revenue was at its lowest. Revenue in Q2 FY27 was the highest in the series, and profit before tax also moved from a loss to a profit.
EBITDA margin reached its low of 2.6% in Q2 FY26 before recovering to 13.1% in Q2 FY27; the latest quarter’s margin was below the 16.1% recorded in Q1 FY27. Net profit bottomed at a loss of ₹4.62 crore in Q3 FY26, then rose to ₹4.83 crore in Q4 FY26 and ₹15.21 crore in Q1 FY27 before easing to ₹13.32 crore in Q2 FY27.
What else did the company announce?
The board approved the unaudited financial results for the quarter and half year ended 30 September 2026 on 19 October 2026, along with the statutory auditors’ report. No dividend or fund-raising decision was reported in the same-day filings.
The board approved the change in designation and re-appointment of Munjal M. Jaykrishna as Managing Director and CEO for three consecutive years from 19 October 2026, subject to shareholder approval. It also approved the re-appointment of Sachin M. Jaykrishna as Whole Time Director and Executive Director for three consecutive years from 2 August 2027, subject to shareholder approval and other necessary approvals. The board revised Sachin M. Jaykrishna’s remuneration from 19 October 2026 to 1 August 2027.
How did AksharChem India shares react?
The results were released after market hours. AksharChem India was down 0.5% after five minutes, 4.5% after 15 minutes and 5.5% after 30 minutes. By the reaction-day close, the stock was 3.9% below its pre-results close; by the next day’s close, it was 8.7% lower, and by five sessions, it was 6.6% lower.
| After the filing | Stock | Dyes And Pigments median |
|---|---|---|
| 5 minutes | −0.5% | |
| 15 minutes | −4.5% | |
| 30 minutes | −5.5% | |
| Reaction day | −3.9% | −1.9% |
| Next day | −8.7% | −2.7% |
| 5 days | −6.6% | −4.1% |
Minutes are measured from the price when the filing appeared; days from the previous close. Source: MarketPing price-reaction measurement.
| Results filed on | Stock on the reaction day |
|---|---|
| 12 August 2026 | +3.9% |
| 21 May 2026 | −5.3% |
| 28 January 2026 | −3.5% |
| 12 November 2025 | −1.3% |
| 25 July 2025 | −6.8% |
| 21 May 2025 | −3.2% |
| 10 February 2025 | −2.8% |
| 12 November 2024 | −2.7% |
Source: MarketPing price-reaction measurement.
Quick answers
What was AksharChem India's revenue in Q2 FY27?
Revenue from operations was ₹160.48 crore, up 79.7% from ₹89.30 crore in Q2 FY26 (standalone).
Did AksharChem India make a profit in Q2 FY27?
Yes. Net profit was ₹13.32 crore, against a net loss of ₹1.37 crore in Q2 FY26.
What was AksharChem India's EPS in Q2 FY27?
Basic earnings per share were ₹16.58, against a loss of ₹1.70 in Q2 FY26.
How did AksharChem India shares react to the Q2 FY27 results?
On the reaction day the stock moved −3.9% from the previous close; the median Dyes And Pigments stock moved −1.9%.
When did AksharChem India announce its Q2 FY27 results?
On 19 October 2026, in a filing to the BSE.
Sources
- Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026 (BSE, 9 October 2026) · PDF
- Board Meeting Outcome for Outcome Of Board Meeting (BSE, 19 October 2026) · PDF
- Unaudited Financial Results (BSE, 19 October 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.